About 20 Trademarks found that are owned by Cosmo Technologies Ltd

Contrast media for use with medical equipment or in medical imaging, namely, endoscopy, x-ray, ultrasound, MRI, PET and CT equipment; Diagnostic agents and reagents for medical use; Diagnostic preparations for medical purposes; Pharmaceutical preparations and substances, namely, prescription medicines in the form of pills, tablets, capsules, caplets, and liquid drops for the treatment of gastrointestinal disorders; Pharmaceutical preparations for treating gastrointestinal disorders; Pharmaceutical preparations for treating gastrointestinal disorders, gastrointestinal diseases or digestive system disorders; Pharmaceutical preparations for the treatment or prevention of IBS (irritable bowel syndrome); Non-prescription medicines, namely, pills, tablets, capsules, caplets, and liquid drops for the treatment of gastrointestinal disorders; Pharmaceutical preparations for treating gastrointestinal disorders; diagnostic agents, preparations and substances for medical purposes, namely, the visual enhancing or visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions in the colon for patients undergoing endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; contrast media for medical and surgical use; contrast media for use with gastroscopic, endoscopic, colonoscopic, sigmoidoscopic, anoscopic, rectoscopic and proctoscopic equipment; pharmaceutical preparations to aid the detection, diagnosis, prevention or treatment of gastroenterological diseases; pharmaceutical preparations for use in gastroenterology, endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations containing methylene blue or dye for visual enhancing or visualization during endoscopic procedures; pharmaceutical preparations containing methylene blue or dye for pharmaceutical, medical and surgical purposes, namely, detection, diagnosis, prevention or treatment of gastroenterological diseases; Medical and surgical dyes, namely, methylene blue dye; Medical dyes for pharmaceutical and diagnostic purposes, namely, the visual enhancing or visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions in the colon for patients undergoing endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations for the diagnosis, prevention or treatment of ulcerative colitis or inflammatory bowel diseases; pharmaceutical preparations for the treatment of fertility, reproductive health, hematology, urology, gynecology, obstetrics, endocrinology, oncology, renalology, immunology and inflammatory diseases, disorders and conditions; pharmaceutical preparations for colon and digestive system health and regulation, for improving energy levels or for maintaining and improving mucous levels and the mucosal lining of the intestines and colon; diarrhea medication; Anti-nausea medication; antiemetic preparations; antibiotic preparations; pharmaceutical preparations for the treatment or prevention of travelers' diarrhea, diarrhea, diverticular disease, diverticulitis or infectious colitis

Contrast media for use with medical equipment or in medical imaging, namely, endoscopy, x-ray, ultrasound, MRI, PET and CT equipment; Diagnostic agents and reagents for medical use; Diagnostic preparations for medical purposes; Pharmaceutical preparations and substances, namely, prescription medicines in the form of pills, tablets, capsules, caplets, and liquid drops for the treatment of gastrointestinal disorders; Pharmaceutical preparations for treating gastrointestinal disorders; Pharmaceutical preparations for treating gastrointestinal disorders, gastrointestinal diseases or digestive system disorders; Pharmaceutical preparations for the treatment or prevention of IBS (irritable bowel syndrome); Non-prescription medicines, namely, pills, tablets, capsules, caplets, and liquid drops for the treatment of gastrointestinal disorders; Pharmaceutical preparations for treating gastrointestinal disorders; diagnostic agents, preparations and substances for medical purposes, namely, the visual enhancing or visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions in the colon for patients undergoing endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; contrast media for medical and surgical use; contrast media for use with gastroscopic, endoscopic, colonoscopic, sigmoidoscopic, anoscopic, rectoscopic and proctoscopic equipment; pharmaceutical preparations to aid the detection, diagnosis, prevention or treatment of gastroenterological diseases; pharmaceutical preparations for use in gastroenterology, endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations containing methylene blue or dye for visual enhancing or visualization during endoscopic procedures; pharmaceutical preparations containing methylene blue or dye for pharmaceutical, medical and surgical purposes, namely, detection, diagnosis, prevention or treatment of gastroenterological diseases; Medical and surgical dyes, namely, methylene blue dye; Medical dyes for pharmaceutical and diagnostic purposes, namely, the visual enhancing or visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions in the colon for patients undergoing endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations for the diagnosis, prevention or treatment of ulcerative colitis or inflammatory bowel diseases; pharmaceutical preparations for the treatment of fertility, reproductive health, hematology, urology, gynecology, obstetrics, endocrinology, oncology, renalology, immunology and inflammatory diseases, disorders and conditions; pharmaceutical preparations for colon and digestive system health and regulation, for improving energy levels or for maintaining and improving mucous levels and the mucosal lining of the intestines and colon; diarrhea medication; Anti-nausea medication; antiemetic preparations; antibiotic preparations; pharmaceutical preparations for the treatment or prevention of travelers' diarrhea, diarrhea, diverticular disease, diverticulitis or infectious colitis

The mark consists of a series of orange spheres which create a circular swirl followed by an abstract light green curved line followed by the stylized term "AEMCOLO" in dark green.

Diagnostic agents, preparations and substances for medical and surgical purposes; Diagnostic agents, preparations and substances for medical purposes, namely, the visual enhancing of polyps, adenomas, carcinomas, early stage cancers and other lesions in the colon for patients undergoing colonoscopy; Diagnostic agents, preparations and substances for medical purposes, namely, the visualization of colonic polyps, adenomas, carcinomas, early stage cancers and other lesions in patients undergoing screening colonoscopy including patients at high risk of colorectal carcinoma (CRC), those with previous history of polyps, adenomas, carcinomas, early stage cancers and other lesions, patients with colorectal cancer and patients with relevant family history; Diagnostic reagents and coloring agent for medical and surgical use; Coloring agent for use with imaging medical equipment; Coloring agent for use with colonoscopic equipment; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the differentiation of the tissues of the intestines and colon and polyps, adenomas, carcinomas, early stage cancers and other lesions thereon; pharmaceutical preparations for use in endoscopic or colonoscopic diagnostic evaluation; pharmaceutical preparations for enhancing visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions during gastrointestinal endoscopic procedures; pharmaceutical preparations for use in gastroenterology for colon and digestive system health and regulation; pharmaceutical preparations for use in endoscopy of the gastrointestinal tract; pharmaceutical preparations and preparations aiding detection, diagnosis, prevention and treatment related to the gastrointestinal field; pharmaceutical preparations and preparations aiding detection, diagnosis, prevention and treatment related to the gastrointestinal endoscopy field; pharmaceutical preparations to aid the detection, diagnosis, prevention and treatment of gastroenterological diseases; pharmaceutical preparations, namely, coloring agent for use in endoscopic procedures; pharmaceutical compositions, namely, coloring agent for use in endoscopy; pharmaceutical preparations for use as reagents for medical use; pharmaceutical preparations, namely, coloring agent for use in endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations containing methylene blue for enhancing visualization during endoscopic procedures; pharmaceutical preparations containing dyes for enhancing visualization during endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations containing methylene blue coloring agent for pharmaceutical, medical and surgical purposes; pharmaceutical preparations containing coloring agent dye for pharmaceutical, medical and surgical purposes; methylene blue for pharmaceutical, medical, surgical and medical diagnostic purposes; dye for pharmaceutical, medical, surgical and medical diagnostic purposes

The mark consists of the term "LUMEBLUE" with a capital "L", "M" and "B", with the letters "LUME" in light blue and the letters "BLUE" in dark blue, all preceded by a stylized icon consisting of two overlapping circular shapes with holes in the middle, the bottom circle being orange fading into grey and the top circle being dark blue fading into light blue.

The mark consists of a series of orange spheres which create a circular swirl followed by an abstract blue curved line followed by the stylized term "AEMCOLO" in blue.

Pharmaceutical preparations for the treatment of travellers' diarrhea, diarrhea, diverticular disease, diverticulitis or infectious colitis; Pharmaceutical preparations for the prevention of travellers' diarrhea, diarrhea, diverticular disease, diverticulitis or infectious colitis; Pharmaceutical preparations and substances for the treatment of gastrointestinal diseases and disorders; Pharmaceutical preparations for the prevention of gastrointestinal diseases and disorders; Pharmaceutical preparations for colon and digestive system health and regulation; Diarrhea medication; Gastro-intestinal treatment preparations; Anti-nauseants; Nausea treatment preparations; Antiemetic preparations; Pharmaceutical agents affecting digestive organs; Antibiotics; Antibiotic preparations

Diagnostic agents, preparations and substances for medical and surgical purposes; Diagnostic agents, preparations and substances for medical purposes, namely, the enhancing of adenomatous, cancerous and other proliferative lesions in the colon for patients undergoing colonoscopy and for the visualization of colonic adenoma in patients undergoing screening colonoscopy including patients at high risk of colorectal carcinoma (CRC), including those with previous history of polyps at prior colonoscopy, patients with colorectal cancer and patients with family history; Diagnostic reagents and contrast media for medical and surgical use; Contrast media for use with imaging medical equipment; Contrast media for use with colonoscopic equipment; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for use in colonoscopy; pharmaceutical preparations for the differentiation of the tissues of the intestines and colon and lesions thereto; pharmaceutical preparations for use in the colonoscopic diagnostic evaluation; methylene blue for pharmaceutical, medical, surgical and medical diagnostic purposes; dye for pharmaceutical, medical, surgical and medical diagnostic purposes; pharmaceutical preparations for use in the endoscopic diagnostic evaluation; pharmaceutical compositions for use in endoscopy; methylene blue for pharmaceutical, medical, surgical and medical diagnostic purposes, namely, for enhancing visualization during colonoscopy; dyes for pharmaceutical, medical, surgical and medical diagnostic purposes, namely, for enhancing visualization during colonoscopy

Diagnostic agents, preparations and substances for medical and surgical purposes; Diagnostic agents, preparations and substances for medical purposes, namely, the enhancing of adenomatous, cancerous and other proliferative lesions in the colon for patients undergoing colonoscopy and for the visualization of colonic adenoma in patients undergoing screening colonoscopy including patients at high risk of colorectal carcinoma (CRC), including those with previous history of polyps at prior colonoscopy, patients with colorectal cancer and patients with family history; Diagnostic reagents and contrast media for medical and surgical use; Contrast media for use with imaging medical equipment; Contrast media for use with colonoscopic equipment; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for use in colonoscopy; pharmaceutical preparations for the differentiation of the tissues of the intestines and colon and lesions thereto; pharmaceutical preparations for use in the colonoscopic diagnostic evaluation; methylene blue for pharmaceutical, medical, surgical and medical diagnostic purposes; dye for pharmaceutical, medical, surgical and medical diagnostic purposes; pharmaceutical preparations for use in the endoscopic diagnostic evaluation; pharmaceutical compositions for use in endoscopy; methylene blue for enhancing visualization during colonoscopy; dyes for enhancing visualization during colonoscopy

Diagnostic agents, preparations and substances for medical and surgical purposes; Diagnostic agents, preparations and substances for medical purposes, namely, the enhancing of adenomatous, cancerous and other proliferative lesions in the colon for patients undergoing colonoscopy and for the visualization of colonic adenoma in patients undergoing screening colonoscopy including patients at high risk of colorectal carcinoma (CRC), including those with previous history of polyps at prior colonoscopy, patients with colorectal cancer and patients with family history; Diagnostic reagents and contrast media for medical and surgical use; Contrast media for use with imaging medical equipment; Contrast media for use with colonoscopic equipment; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for use in colonoscopy; pharmaceutical preparations for the differentiation of the tissues of the intestines and colon and lesions thereto; pharmaceutical preparations for use in the colonoscopic diagnostic evaluation; methylene blue for pharmaceutical, medical, surgical and medical diagnostic purposes; dye for pharmaceutical, medical, surgical and medical diagnostic purposes

The color(s) blue is/are claimed as a feature of the mark.

Pharmaceutical preparations; Medicines for human purposes; Medical reagent; Diagnostic agents, preparations and substances for medical and surgical purposes; Diagnostic agents, preparations and substances for medical purposes, namely, the visual enhancing of polyps, adenomas, carcinomas, early stage cancers and other lesions in the colon for patients undergoing colonoscopy; Diagnostic agents, preparations and substances for medical purposes, namely, the visualization of colonic polyps, adenomas, carcinomas, early stage cancers and other lesions in patients undergoing screening colonoscopy including patients at high risk of colorectal carcinoma (CRC), those with previous history of polyps, adenomas, carcinomas, early stage cancers and other lesions, patients with colorectal cancer and patients with relevant family history; Diagnostic reagents and coloring agent for medical and surgical use; Coloring agent for use with imaging medical equipment; Coloring agent for use with colonoscopic equipment; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the differentiation of the tissues of the intestines and colon and polyps, adenomas, carcinomas, early stage cancers and other lesions thereon; pharmaceutical preparations for use in endoscopic or colonoscopic diagnostic evaluation; pharmaceutical preparations for enhancing visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions during gastrointestinal endoscopic procedures; pharmaceutical preparations for use in gastroenterology for colon and digestive system health and regulation; pharmaceutical preparations for use in endoscopy of the gastrointestinal tract; pharmaceutical preparations and preparations aiding detection, diagnosis, prevention and treatment related to the gastrointestinal field; pharmaceutical preparations and preparations aiding detection, diagnosis, prevention and treatment related to the gastrointestinal endoscopy field; pharmaceutical preparations to aid the detection, diagnosis, prevention and treatment of gastroenterological diseases; pharmaceutical preparations, namely, coloring agent for use in endoscopic procedures; pharmaceutical compositions, namely, coloring agent for use in endoscopy; pharmaceutical preparations for use as reagents for medical use; pharmaceutical preparations, namely, coloring agent for use in endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations containing methylene blue for enhancing visualization during endoscopic procedures; pharmaceutical preparations containing dyes for enhancing visualization during endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations containing methylene blue coloring agent for pharmaceutical, medical and surgical purposes; pharmaceutical preparations containing coloring agent dye for pharmaceutical, medical and surgical purposes; methylene blue for pharmaceutical, medical, surgical and medical diagnostic purposes; dye for pharmaceutical, medical, surgical and medical diagnostic purposes